4582 — SymBio Pharmaceuticals Share News
0.000.00%
Last trade - 00:00Brief: SymBio Pharmaceuticals announces shareholding structure change
Brief: SymBio announces incorporation of its U.S. subsidiary
Table: SymBio Pharmaceuticals -Q1 parent results
Brief: Onconova enrolls first patient in Europe for Phase 3 trial of rigosertib
Table: SymBio Pharmaceuticals -2015 parent results
RCS - SymBio Pharma - Edison issues ADR update - SymBio Pharmaceuticals
Table: SymBio Pharmaceuticals -9-MTH parent results
Brief: Medicines Co and SymBio Pharmaceuticals establish strategic partnership